Sera Prognostics, Inc.

$SERA is up over 200% PreTRM pregnancy study showed better than expected efficacy

Share this article:

About the Author:

Sera Prognostics, Inc.

Joey Ramson

PRISM Market View Alerts

Get your dose of PRISM Market
View news, right in your inbox

Mailchimp Signup